title: Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia A.
abstract: Hemophilia is a rare genetic bleeding disorder that, if not adequately controlled, is associated with life-threatening bleeding events and serious and costly complications, primarily from joint damage. The advent of effective clotting factor replacement therapy for patients with hemophilia is considered one of the foremost medical advances of the 20th century. The last 3 decades of experience in hemophilia care have witnessed the effectiveness of the care of patients with hemophilia within specialized comprehensive care centers, advances in factor replacement therapies, the benefits of prophylaxis over on-demand replacement therapy, and the role of aggressive management of joint disease to prevent dysfunction. Ongoing challenges, including the management of inhibitors to factor therapies and the consequences of thousands of patients with hemophilia becoming infected with human immunodeficiency virus and hepatitis C virus in the 1980s from contaminated plasma-derived factor concentrates, have highlighted the need for vigilance with respect to clotting factor product safety, access to care, and a full complement of choice of factor replacement therapies. Advate((R)) (antihemophilic factor [recombinant] plasma/albumin-free method [rAHF-PFM]) is the first recombinant factor VIII therapy manufactured without human or animal protein additives to eliminate the risk of pathogen transmission that could be carried by these additives. Preclinical studies established bioequivalence with recombinant antihemophilic factor (Recombinate((R))), a product with 16 years of clinical experience. Currently licensed in 44 countries worldwide, rAHF-PFM has over 7 years of clinical research within 5 global studies supporting its safety and efficacy in the treatment of patients with hemophilia A.
authors.affiliation: Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI, USA. ummdswp@med.umich.edu
authors.forename: Steven
authors.initials: S
authors.lastname: Pipe
references.citation: Pediatrics. 2001 Dec;108(6):E105
references.pmid: 11731632
references.citation: Transfusion. 2004 Aug;44(8):1179-85
references.pmid: 15265122
references.citation: J Intern Med. 1992 Jul;232(1):25-32
references.pmid: 1640190
references.citation: Haemophilia. 2004 Mar;10 Suppl 1:63-70
references.pmid: 14987251
references.citation: Blood. 2000 Jul 15;96(2):437-42
references.pmid: 10887103
references.citation: Haemophilia. 2003 Jan;9(1):1-23
references.pmid: 12558775
references.citation: Thromb Haemost. 2008 May;99(5):840-50
references.pmid: 18449413
references.citation: Haemophilia. 1999 Nov;5(6):378-85
references.pmid: 10583523
references.citation: Blood. 2007 Jun 1;109(11):4648-54
references.pmid: 17289808
references.citation: Thromb Haemost. 1997 Apr;77(4):660-7
references.pmid: 9134639
references.citation: Thromb Haemost. 1996 Dec;76(6):1120
references.pmid: 8972042
references.citation: Thromb Res. 2002 Mar 1;105(5):391-400
references.pmid: 12062540
references.citation: N Engl J Med. 2007 Aug 9;357(6):535-44
references.pmid: 17687129
references.citation: Haemophilia. 2005 Nov;11(6):589-97
references.pmid: 16236108
references.citation: Soc Sci Med. 2001 Oct;53(8):1081-94
references.pmid: 11556777
references.citation: Haemophilia. 2000 Jan;6(1):23-32
references.pmid: 10632738
references.citation: Haemophilia. 2003 Jan;9(1):38-49
references.pmid: 12558777
references.citation: MMWR Suppl. 1987 Dec 18;36(6):1-48
references.pmid: 3123906
references.citation: Lancet. 2004 Aug 7-13;364(9433):527-9
references.pmid: 15302196
references.citation: Haemophilia. 2005 Nov;11(6):571-82
references.pmid: 16236106
references.citation: Thromb Haemost. 2008 Aug;100(2):217-23
references.pmid: 18690340
references.citation: Am J Hematol. 1998 Dec;59(4):288-94
references.pmid: 9840909
references.citation: Thromb Haemost. 1999 Mar;81(3):476-7
references.pmid: 10102490
references.citation: Bull World Health Organ. 1995;73(5):691-701
references.pmid: 8846496
references.citation: Br J Haematol. 2009 Jan;144(1):14-23
references.pmid: 18950452
references.citation: Semin Hematol. 2004 Jan;41(1 Suppl 2):1-16; discussion 16-8
references.pmid: 15071785
references.citation: Euro Surveill. 2005 Feb;10(2):17-9
references.pmid: 15735312
references.citation: Semin Hematol. 2006 Apr;43(2 Suppl 3):S23-7
references.pmid: 16631824
references.citation: Blood. 1994 May 1;83(9):2428-35
references.pmid: 8167332
references.citation: Thromb Haemost. 2001 Mar;85(3):560
references.pmid: 11307831
references.citation: MMWR Morb Mortal Wkly Rep. 1982 Jul 16;31(27):365-7
references.pmid: 6815443
references.citation: Haemophilia. 2003 May;9 Suppl 1:10-7; discussion 18
references.pmid: 12709032
references.citation: Haemophilia. 2002 Jan;8(1):44-50
references.pmid: 11886464
references.citation: Haemophilia. 2003 May;9(3):272-8
references.pmid: 12694517
references.citation: N Engl J Med. 2003 Sep 25;349(13):1236-45
references.pmid: 14500806
references.citation: Haemophilia. 2004 Sep;10(5):428-37
references.pmid: 15357767
references.citation: Artif Cells Blood Substit Immobil Biotechnol. 2000 Sep;28(5):375-83
references.pmid: 11009110
references.citation: Thromb Haemost. 2000 Jun;83(6):811-6
references.pmid: 10896230
references.citation: J Thromb Haemost. 2008 Aug;6(8):1319-26
references.pmid: 18503631
references.citation: Lancet. 2004 Feb 7;363(9407):417-21
references.pmid: 14962520
references.citation: Am J Hematol. 2001 Apr;66(4):229-40
references.pmid: 11279632
references.citation: Vasc Health Risk Manag. 2007;3(5):555-65
references.pmid: 18078007
references.citation: J Neurol Neurosurg Psychiatry. 2004 Mar;75 Suppl 1:i36-42
references.pmid: 14978149
references.citation: Haemophilia. 2006 Mar;12 Suppl 1:16-20; discussion 26-8
references.pmid: 16445813
references.citation: Lancet. 2004 Aug 7-13;364(9433):477-9
references.pmid: 15302172
references.citation: Thromb Haemost. 2005 Mar;93(3):457-67
references.pmid: 15735795
references.citation: Transfusion. 2001 Mar;41(3):338-43
references.pmid: 11274587